share_log

华兰生物(002007.SZ):静注人免疫球蛋白(IVIG)(10%)处于III期临床试验阶段

Hualan Biology (002007.SZ): Intravenous human immunoglobulin (IVIG) (10%) is in phase III clinical trials

Gelonghui Finance ·  Apr 15 04:04

Gelonghui, April 15 | Hualan Biology (002007.SZ) said on the investor interactive platform that intravenous human immunoglobulin (IVIG) (10%) developed by the company is in phase III clinical trials.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment